212 related articles for article (PubMed ID: 37014523)
21. High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma.
Haveman LM; van Ewijk R; van Dalen EC; Breunis WB; Kremer LC; van den Berg H; Dirksen U; Merks JH
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011406. PubMed ID: 34472084
[TBL] [Abstract][Full Text] [Related]
22. Ewing sarcoma: investigational mono- and combination therapies in clinical trials.
Gartrell J; Rodriguez-Galindo C
Expert Opin Investig Drugs; 2021 Jun; 30(6):653-663. PubMed ID: 33870845
[TBL] [Abstract][Full Text] [Related]
23. Prospects and challenges for the development of new therapies for Ewing sarcoma.
Grohar PJ; Helman LJ
Pharmacol Ther; 2013 Feb; 137(2):216-24. PubMed ID: 23085431
[TBL] [Abstract][Full Text] [Related]
24. Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
van Maldegem AM; Bovée JV; Peterse EF; Hogendoorn PC; Gelderblom H
Eur J Cancer; 2016 Jan; 53():171-80. PubMed ID: 26765686
[TBL] [Abstract][Full Text] [Related]
25. CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma.
Flores G; Everett JH; Boguslawski EA; Oswald BM; Madaj ZB; Beddows I; Dikalov S; Adams M; Klumpp-Thomas CA; Kitchen-Goosen SM; Martin SE; Caplen NJ; Helman LJ; Grohar PJ
Mol Cancer Ther; 2020 May; 19(5):1183-1196. PubMed ID: 32127464
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.
Takenaka S; Naka N; Obata H; Joyama S; Hamada K; Imura Y; Kakunaga S; Aoki Y; Ueda T; Araki N; Yoshikawa H
Jpn J Clin Oncol; 2016 Jun; 46(6):522-8. PubMed ID: 27008849
[TBL] [Abstract][Full Text] [Related]
27. IGF-1R/MDM2 relationship confers enhanced sensitivity to RITA in Ewing sarcoma cells.
Di Conza G; Buttarelli M; Monti O; Pellegrino M; Mancini F; Pontecorvi A; Scotlandi K; Moretti F
Mol Cancer Ther; 2012 Jun; 11(6):1247-56. PubMed ID: 22461661
[TBL] [Abstract][Full Text] [Related]
28. Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma.
Zajec Ž; Dernovšek J; Distel M; Gobec M; Tomašič T
Bioorg Chem; 2023 Feb; 131():106311. PubMed ID: 36495678
[TBL] [Abstract][Full Text] [Related]
29. Precision medicine in Ewing sarcoma: a translational point of view.
Gargallo P; Juan A; Yáñez Y; Dolz S; Segura V; Castel V; Cañete A
Clin Transl Oncol; 2020 Sep; 22(9):1440-1454. PubMed ID: 32026343
[TBL] [Abstract][Full Text] [Related]
30. Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.
Jedlicka P
Int J Clin Exp Pathol; 2010 Mar; 3(4):338-47. PubMed ID: 20490326
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.
Choy E; Butrynski JE; Harmon DC; Morgan JA; George S; Wagner AJ; D'Adamo D; Cote GM; Flamand Y; Benes CH; Haber DA; Baselga JM; Demetri GD
BMC Cancer; 2014 Nov; 14():813. PubMed ID: 25374341
[TBL] [Abstract][Full Text] [Related]
32. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract][Full Text] [Related]
33. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
[TBL] [Abstract][Full Text] [Related]
34. Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth.
Vasileva E; Warren M; Triche TJ; Amatruda JF
Elife; 2022 Mar; 11():. PubMed ID: 35285802
[TBL] [Abstract][Full Text] [Related]
35. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
Mascarenhas L; Felgenhauer JL; Bond MC; Villaluna D; Femino JD; Laack NN; Ranganathan S; Meyer J; Womer RB; Gorlick R; Krailo MD; Marina N
Pediatr Blood Cancer; 2016 Mar; 63(3):493-8. PubMed ID: 26579879
[TBL] [Abstract][Full Text] [Related]
36. Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.
Harlow ML; Maloney N; Roland J; Guillen Navarro MJ; Easton MK; Kitchen-Goosen SM; Boguslawski EA; Madaj ZB; Johnson BK; Bowman MJ; D'Incalci M; Winn ME; Turner L; Hostetter G; Galmarini CM; Aviles PM; Grohar PJ
Cancer Res; 2016 Nov; 76(22):6657-6668. PubMed ID: 27697767
[TBL] [Abstract][Full Text] [Related]
37. [Malignant round cell tumors : The Ewing sarcoma and beyond].
Haybaeck J; Roessner A
Pathologe; 2020 Mar; 41(2):116-122. PubMed ID: 32060684
[TBL] [Abstract][Full Text] [Related]
38. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
[TBL] [Abstract][Full Text] [Related]
39. An Oral Formulation of YK-4-279: Preclinical Efficacy and Acquired Resistance Patterns in Ewing Sarcoma.
Lamhamedi-Cherradi SE; Menegaz BA; Ramamoorthy V; Aiyer RA; Maywald RL; Buford AS; Doolittle DK; Culotta KS; O'Dorisio JE; Ludwig JA
Mol Cancer Ther; 2015 Jul; 14(7):1591-604. PubMed ID: 25964201
[TBL] [Abstract][Full Text] [Related]
40. Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.
Ban J; Aryee DN; Fourtouna A; van der Ent W; Kauer M; Niedan S; Machado I; Rodriguez-Galindo C; Tirado OM; Schwentner R; Picci P; Flanagan AM; Berg V; Strauss SJ; Scotlandi K; Lawlor ER; Snaar-Jagalska E; Llombart-Bosch A; Kovar H
Cancer Res; 2014 Nov; 74(22):6578-88. PubMed ID: 25281719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]